Forbion General Partner Marco Boorsma, PhD, and Forbion Operating Partner and VectorY CEO, Sander van Deventer, MD, PhD, will both be speakers at the first ever "Cell and Gene Therapy Summit" to be held in Brussels on 24-25 April.
The conference is part of The Economist series of the Economist Impact event series, and will focus on "Enabling market access, policy and delivery." Both Marco and Sander will participate on the panel "Investor Insights: what's happening in the market" which takes place on 25 April at 10:00 CET. Click here for more details on the Economist Impact website.